Connect with us
Sartorius Stedim Biotech reported a slight revenue decrease and significant drops in net profit and EBITDA for the first half of 2024, leading to a cautious...
The Spanish biotechnology sector, detailed in the AseBio 2023 Report, generated over €16.6 billion in 2022, 1.5% of GDP, and contributed 162,845 jobs. Private financing reached...
Nowture oversees accelerating the technological transformation of these companies. Specifically, the company obtains the rights to exploit the patent, that is, it becomes the owner of...
Santana will be responsible, among other tasks, for Doctomatic's deployment in Latin America, which the company expects to be completed within the next year after having...
Algernon Pharmaceuticals Inc. is a Canadian clinical-stage drug development company with a promising new treatment for post-stroke recovery based on sub-psychedelic doses of DMT. The company...
Some approaches to developing pharmaceuticals are more efficient than others. Algernon Pharmaceuticals provides a perfect example of the efficient way, with a large portion of its...
The Iqvia report also focuses on the place of origin of the research. This confirms the decline that is being experienced in Europe in the field...
The response to Covid-19 by governments and the medical community demonstrated the possibilities of rapid testing and vaccine development. Now one company, Alercell, is looking to...
The blood-brain barrier is a major hurdle in treating a whole range of diseases affecting the CNS. While it serves a vital role in protecting against...
Estimated as a $3 billion opportunity for Bioasis Technologies, the company's xB3 platform is set to revolutionize the treatment of neurological disease. The technology helps deliver...